Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie A Smoley

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Cancer Genetics and Cytogenetics|December 31, 2003
A novel tricolor, dual-fusion fluorescence in situ hybridization method to detect BCR/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemiaStephanie A Smoley, Stephanie R Brockman, Sarah F Paternoster, et al.
Clinical Case Reports|February 18, 2021
Prenatal characterization of a novel inverted <i>SMAD2</i> duplication by mate pair sequencing in a fetus with dextrocardiaCinthya J Zepeda-Mendoza, Anna Essendrup, Stephanie A Smoley, et al.
Leukemia Research|January 3, 2009
Validation of a new three-color fluorescence in situ hybridization (FISH) method to detect CHIC2 deletion, FIP1L1/PDGFRA fusion and PDGFRA translocationsStephanie R Fink, Kimberly J Belongie, Sarah F Paternoster, et al.
Cancer Genetics and Cytogenetics|February 27, 2007
Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20qStephanie A Smoley, Stephanie R Fink, Sarah F Paternoster, et al.
Cold Spring Harbor Molecular Case Studies|June 5, 2019
Elucidating a false-negative <i>MYC</i> break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with <i>IGH/MYC</i> and <i>IGH/BCL2</i> rearrangementsJess F Peterson, Beth A Pitel, Stephanie A Smoley, et al.
Leukemia Research|November 28, 2006
Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with LenalidomideYing S Zou, Stephanie R Fink, Kimberly J Stockero, et al.
British Journal of Haematology|February 18, 2011
Biological evaluation of CpG stimulation of normal human B-cells: implications for B-cell biology and cytogenetic analysis of CLL B-cellsXiaosheng Wu, Stephanie A Smoley, Mark A Peterson, et al.
Human Pathology|January 31, 2017
Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulationJoshua R Menke, George Vasmatzis, Stephen Murphy, et al.
Leukemia Research|January 22, 2005
Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemiaStephanie R Fink, Sarah F Paternoster, Stephanie A Smoley, et al.
Blood Cancer Journal|October 3, 2019
Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusionRoss A Rowsey, Stephanie A Smoley, Cynthia M Williamson, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Cancer Genetics and Cytogenetics|December 31, 2003
A novel tricolor, dual-fusion fluorescence in situ hybridization method to detect BCR/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemiaStephanie A Smoley, Stephanie R Brockman, Sarah F Paternoster, et al.
Clinical Case Reports|February 18, 2021
Prenatal characterization of a novel inverted <i>SMAD2</i> duplication by mate pair sequencing in a fetus with dextrocardiaCinthya J Zepeda-Mendoza, Anna Essendrup, Stephanie A Smoley, et al.
Leukemia Research|January 3, 2009
Validation of a new three-color fluorescence in situ hybridization (FISH) method to detect CHIC2 deletion, FIP1L1/PDGFRA fusion and PDGFRA translocationsStephanie R Fink, Kimberly J Belongie, Sarah F Paternoster, et al.
Cancer Genetics and Cytogenetics|February 27, 2007
Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20qStephanie A Smoley, Stephanie R Fink, Sarah F Paternoster, et al.
Cold Spring Harbor Molecular Case Studies|June 5, 2019
Elucidating a false-negative <i>MYC</i> break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with <i>IGH/MYC</i> and <i>IGH/BCL2</i> rearrangementsJess F Peterson, Beth A Pitel, Stephanie A Smoley, et al.
Leukemia Research|November 28, 2006
Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with LenalidomideYing S Zou, Stephanie R Fink, Kimberly J Stockero, et al.
British Journal of Haematology|February 18, 2011
Biological evaluation of CpG stimulation of normal human B-cells: implications for B-cell biology and cytogenetic analysis of CLL B-cellsXiaosheng Wu, Stephanie A Smoley, Mark A Peterson, et al.
Human Pathology|January 31, 2017
Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulationJoshua R Menke, George Vasmatzis, Stephen Murphy, et al.
Leukemia Research|January 22, 2005
Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemiaStephanie R Fink, Sarah F Paternoster, Stephanie A Smoley, et al.
Blood Cancer Journal|October 3, 2019
Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusionRoss A Rowsey, Stephanie A Smoley, Cynthia M Williamson, et al.
Pageof 4